HRS7415
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 08, 2022
A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=67 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1